Weight-Loss drug tested for patients who regain weight after surgery
NCT ID NCT07382180
Summary
This study looked at how the weight-loss medication tirzepatide works for people in two real-world situations: those who have regained a significant amount of weight after bariatric surgery, and those who need to lose weight before having obesity surgery. Researchers followed 254 adults for 6 months to see how much weight they lost and to check for side effects. All patients received the drug as part of their normal medical care; this was an observational study to see how it performs outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, MORBID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Head of bariatric surgery
Naples, 80131, Italy
Conditions
Explore the condition pages connected to this study.